- Directory
- September 2025
Global
From €1720EUR$1,950USD£1,489GBP
- Report
- April 2025
- 220 Pages
Global
From €1761EUR$1,997USD£1,525GBP
- Newsletter
- September 2025
Global
€2641EUR$2,995USD£2,287GBP
- Report
- June 2025
- 193 Pages
Global
From €4366EUR$4,950USD£3,779GBP
- Report
- June 2025
- 105 Pages
Global
From €3043EUR$3,450USD£2,634GBP
- Report
- June 2025
- 180 Pages
Global
From €3528EUR$4,000USD£3,054GBP
- Report
- February 2025
- 135 Pages
Global
From €3636EUR$4,123USD£3,147GBP
€4277EUR$4,850USD£3,703GBP
- Report
- January 2025
- 120 Pages
Global
€4990EUR$6,061USD£4,471GBP
- Report
- October 2024
- 83 Pages
Global
From €4277EUR$4,850USD£3,703GBP
- Report
- September 2024
- 118 Pages
Global
From €3969EUR$4,500USD£3,436GBP
- Report
- January 2025
- 142 Pages
Asia Pacific
From €2866EUR$3,250USD£2,481GBP
- Report
- November 2024
- 75 Pages
United States
From €3484EUR$3,950USD£3,016GBP
- Report
- October 2024
- 100 Pages
Asia Pacific
From €4366EUR$4,950USD£3,779GBP
- Report
- January 2025
- 140 Pages
Asia Pacific
From €3528EUR$4,000USD£3,054GBP
- Report
- May 2025
- 85 Pages
United States
From €3087EUR$3,500USD£2,672GBP
- Report
- April 2025
- 142 Pages
North America
From €3043EUR$3,450USD£2,634GBP
- Report
- April 2025
- 163 Pages
Europe
From €3043EUR$3,450USD£2,634GBP
- Report
- April 2025
- 161 Pages
Asia Pacific
From €3043EUR$3,450USD£2,634GBP
- Report
- October 2024
- 139 Pages
Middle East, Africa
From €3043EUR$3,450USD£2,634GBP
- Report
- June 2025
- 98 Pages
Europe
From €3484EUR$3,950USD£3,016GBP

T Cell Therapies are a type of biotechnology that involves the use of a patient's own T cells to treat diseases. T cells are a type of white blood cell that play a key role in the body's immune system. T Cell Therapies involve the extraction of T cells from a patient, engineering them to recognize and attack specific targets, and then reintroducing them into the patient's body. This type of therapy has been used to treat a variety of cancers, including leukemia, lymphoma, and multiple myeloma. It has also been used to treat autoimmune diseases, such as rheumatoid arthritis and Crohn's disease.
T Cell Therapies are a rapidly growing field of biotechnology, with many companies investing in research and development. Companies such as Kite Pharma, Juno Therapeutics, and Novartis are leading the way in developing and commercializing T Cell Therapies. Other companies, such as Gilead Sciences, Celgene, and Regeneron, are also investing in the field. Show Less Read more